Is SARS-CoV-2 infection an emerging risk factor for splanchnic venous thrombosis?

11Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

OBJECTIVE: Thrombosis represents one of the most feared complications of the COronaVIrus Disease-2019 (COVID-19). Although pulmonary embolism and deep venous thrombosis are the most described complications, some investigations reported thrombotic localization also in the splanchnic venous district. METHODS: We describe the case of a patient with SARS-CoV-2 infection presenting with abdominal pain and diagnosed with portal vein thrombosis. In addition, we shortly review available literature supporting the possible role of COVID-19 as leading cause of splanchnic venous thrombosis. RESULTS: After in-depth diagnostic workup, we excluded the commonest causes of portal thrombosis and concluded that SARS-CoV-2 infection represented the main explanation of this finding. CONCLUSIONS: Our study warns the clinicians to maintain a high index of suspicion for thrombosis in patients diagnosed with SARS-CoV-2 infection manifesting gastrointestinal symptoms. An appropriate diagnostic work-up could allow to obtain an early diagnosis and consequently improve the clinical outcome of patients.

Cite

CITATION STYLE

APA

Tripolino, C., Pizzini, A. M., Zaccaroni, S., Cicognani, C., Dapporto, S., Cipollini, M. L., … Silingardi, M. (2021). Is SARS-CoV-2 infection an emerging risk factor for splanchnic venous thrombosis? Clinical Hemorheology and Microcirculation, 79(2), 347–355. https://doi.org/10.3233/CH-211256

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free